analgin solution for i/v and i/m injection
open joint stock company "borisovskiy zavod medicinskikh preparatov" - metamizole (metamizole sodium) - solution for i/v and i/m injection - 500mg/ml
sedalgin plus tablets
balkanpharma-dupnitsa ad - metamizole (metamizole sodium), caffeine, thiamine hydrochloride - tablets - 500mg+ 50mg+ 38,75mg
spasmalgon 500mg/2mg/0,02mg/ml solution for injection solution for i/m injection
sopharma jsc - metamizole (metamizole sodium), pitofenone (pitofenone hydrochloride), fenpiverinium bromide - solution for i/m injection - 500mg/ml+ 2mg/ml+ 0,02mg/ml
spasmalgon 500mg/2mg/0,02mg/ml solution for injection solution for i/m injection
sopharma jsc - metamizole (metamizole sodium), pitofenone (pitofenone hydrochloride), fenpiverinium bromide - solution for i/m injection - 500mg/ml+ 2mg/ml+ 0,02mg/ml
paralgin-50 500 mg/ml solution for injection (i.m.)
p & d medivet distribution, inc.; distributor: p & d medivet distribution, inc. - metamizole sodium (vet.) - solution for injection (i.m.) - 500 mg/ml
saphalgin 400mg/ml solution for injection (im/iv)
nelpa lifescience, inc.; distributor: nelpa lifescience, inc. - metamizole sodium (vet.) - solution for injection (im/iv) - 400mg/ml
novasul syrup
metamizole sodium - syrup - 50 g/ml
pyrimed 500 mg (50% w/v) per ml solution for injection (im)
p & d medivet distribution inc.; distributor: p & d medivet distribution inc. - metamizole sodium (vet.) - solution for injection (im) - 500 mg (50% w/v) per ml
novasul solution for injection
metamizole sodium - solution for injection - 500 mg/ml
epilim syrup
sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: sorbitol; sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; saccharin sodium; brilliant scarlet 4r; purified water; sucrose; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate